EARLY CELLULAR REJECTION TREATED WITH HIGH-DOSE INTRAVENOUS CORTICOSTEROID-THERAPY IS ASSOCIATED WITH A DECREASE IN THE INCIDENCE OF STEROID-RESISTANT REJECTION AND GRAFT FAILURE FROM REJECTION
Rh. Wiesner et al., EARLY CELLULAR REJECTION TREATED WITH HIGH-DOSE INTRAVENOUS CORTICOSTEROID-THERAPY IS ASSOCIATED WITH A DECREASE IN THE INCIDENCE OF STEROID-RESISTANT REJECTION AND GRAFT FAILURE FROM REJECTION, Transplantation proceedings, 25(2), 1993, pp. 1791-1793